Dec 22, 2024, 17:18
Sam Klempner: Proof of principle in KRAS G12C mutation in colorectal cancer
Sam Klempner, Associate Professor at Harvard Medical School, posted on X about recent paper by him as co-author, titled “Anti-KRAS G12C and Anti-EGFR Rechallenge in Chemotherapy-Refractory KRAS G12C–Mutated Colorectal Cancer: A Case Report” published on Journal of Clinical Oncology.
Authors: Linda Morris, Leontios Pappas, Aditya Pandey, Harshabad Singh, Samuel Klempner, Bennett Caughey
“Proof of principle in KRAS G12C in colorectal cancer, analogous to EGFR rechallenge in RAS WT Colon cancer.
Anti-KRAS G12C + Anti-EGFR Rechallenge in Chemotherapy-Refractory KRAS G12C–Mutated Colorectal Cancer.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 17:18
Dec 22, 2024, 16:46
Dec 22, 2024, 14:35
Dec 22, 2024, 14:32
Dec 22, 2024, 14:19